CORC  > 华南理工大学
Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials
Mai, Ruiqin[1]; Zhou, Songxia[2]; Zhong, Weixiang[3]; Rong, Siming[2]; Cong, Zhichao[2]; Li, Yunxian[2]; Xie, Qizhi[2]; Chen, Huanming[2]; Li, Xiaoyun[2]; Liu, Shuhui[2]
刊名ONCOTARGET
2015
卷号6页码:28502-28512
关键词combing BRAF and MEK inhibition targeted therapy melanoma
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2210890
专题华南理工大学
作者单位1.[1]Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Lab Med, Shantou, Guangdong, Peoples R China
2.[2]Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China
3.[3]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China
4.[4]Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada
推荐引用方式
GB/T 7714
Mai, Ruiqin[1],Zhou, Songxia[2],Zhong, Weixiang[3],et al. Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials[J]. ONCOTARGET,2015,6:28502-28512.
APA Mai, Ruiqin[1].,Zhou, Songxia[2].,Zhong, Weixiang[3].,Rong, Siming[2].,Cong, Zhichao[2].,...&Zhang, Guohong[2,4].(2015).Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials.ONCOTARGET,6,28502-28512.
MLA Mai, Ruiqin[1],et al."Therapeutic efficacy of combined BRAF and MEK inhibition in metastatic melanoma: a comprehensive network meta-analysis of randomized controlled trials".ONCOTARGET 6(2015):28502-28512.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace